The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., Baas, F., & Borst, P. (1997) · PubMed · Cited by 882
Jonker, J. W., Buitelaar, M., Wagenaar, E., van der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plösch, T., Kuipers, F., Elferink, R. P. J. O., Rosing, H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202607599 · Cited by 822
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
Schuetz, J. D., Connelly, M. C., Sun, D., Paibir, S. G., Flynn, P. M., Srinivas, R. V., Kumar, A., & Fridland, A. (1999) · Nature Medicine · doi:10.1038/12487 · Cited by 575
Self-citationThe SLC22 drug transporter family
Koepsell, H., & Endou, H. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1089-9 · Cited by 525
van Aubel, R. A. M. H., Smeets, P. H. E., Peters, J. G. P., Bindels, R. J. M., & Russel, F. G. M. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133595 · Cited by 501
Cellular and molecular aspects of drug transport in the kidney
Inui, K.-I., Masuda, S., & Saito, H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00251.x · Cited by 450
Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy
Leggas, M., Adachi, M., Scheffer, G. L., Sun, D., Wielinga, P., Du, G., Mercer, K. E., Zhuang, Y., Panetta, J. C., Johnston, B., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7612-7621.2004 · Cited by 414
Self-citationNishimura, M., & Naito, S. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.452 · Cited by 388
Lalezari, J. P., Stagg, R. J., Kuppermann, B. D., Holland, G. N., Kramer, F., Ives, D. V., Youle, M., Robinson, M. R., Drew, W. L., & Jaffe, H. S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-4-199702150-00001 · Cited by 372
De Clercq, E. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.4.569-596.2003 · Cited by 369
Reid, G., Wielinga, P., Zelcer, N., de Haas, M., van Deemter, L., Wijnholds, J., Balzarini, J., & Borst, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1094 · Cited by 368
HO, E. S., LIN, D. C., MENDEL, D. B., & CIHLAR, T. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v113383 · Cited by 356
Cihlar, T., Lin, D. C., Pritchard, J. B., Fuller, M. D., Mendel, D. B., & Sweet, D. H. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23084-4 · Cited by 345
Rius, M., Nies, A. T., Hummel-Eisenbeiss, J., Jedlitschky, G., & Keppler, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50331 · Cited by 324
Clinical Pharmacokinetics of the Antiviral Nucleotide Analogues Cidofovir and Adefovir
Cundy, K. C. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936020-00004 · Cited by 303
Gallant, J. E., Parish, M. A., Keruly, J. C., & Moore, R. D. (2005) · Clinical Infectious Diseases · doi:10.1086/428840 · Cited by 302
Schaub, T. P., Kartenbeck, J., König, J., Vogel, O., Witzgall, R., Kriz, W., & Keppler, D. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v881213 · Cited by 294
ZELCER, N., REID, G., WIELINGA, P., KUIL, A., van der HEIJDEN, I., SCHUETZ, J. D., & BORST, P. (2003) · Biochemical Journal · doi:10.1042/bj20021886 · Cited by 281
Self-citationFunctional Analysis of SNPs Variants of BCRP/ABCG2
Kondo, C., Suzuki, H., Itoda, M., Ozawa, S., Sawada, J.-I., Kobayashi, D., Ieiri, I., Mine, K., Ohtsubo, K., & Sugiyama, Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045245.21637.d4 · Cited by 264
Self-citationVan Aubel, R. A. M. H., Smeets, P. H. E., van den Heuvel, J. J. M. W., & Russel, F. G. M. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00133.2004 · Cited by 246
Molecular physiology of renal organic anion transporters
Sekine, T., Miyazaki, H., & Endou, H. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00439.2004 · Cited by 244
Cihlar, T., Ho, E. S., Lin, D. C., & Mulato, A. S. (2001) · Nucleosides, Nucleotides and Nucleic Acids · doi:10.1081/ncn-100002341 · Cited by 241
Assem, M., Schuetz, E. G., Leggas, M., Sun, D., Yasuda, K., Reid, G., Zelcer, N., Adachi, M., Strom, S., Evans, R. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314111200 · Cited by 240
Self-citationHIV-Associated Renal Diseases and Highly Active Antiretroviral Therapy--Induced Nephropathy
Roling, J., Schmid, H., Fischereder, M., Draenert, R., & Goebel, F. D. (2006) · Clinical Infectious Diseases · doi:10.1086/503566 · Cited by 236
Transporters and Renal Drug Elimination
Lee, W., & Kim, R. B. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121856 · Cited by 222
Kahn, J. (1999) · JAMA · doi:10.1001/jama.282.24.2305 · Cited by 199
Maher, J. M., Slitt, A. L., Cherrington, N. J., Cheng, X., & Klaassen, C. D. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.003780 · Cited by 195
Zollner, G., Wagner, M., Moustafa, T., Fickert, P., Silbert, D., Gumhold, J., Fuchsbichler, A., Halilbasic, E., Denk, H., Marschall, H.-U., et al. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00490.2005 · Cited by 178
Organic anion transporter (Slc22a) family members as mediators of toxicity
Sweet, D. H. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.016 · Cited by 150 · cited 2×
“multispecific organic anion and cation transport systems (Inui et al., 2000; Koepsell and Endou, 2004; Lee and Kim, 2004; Sweet, 2005; Wright, 2005; Sekine et al., 2006).”
BackgroundMulato, A. S., Ho, E. S., & Cihlář, T. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38862-7 · Cited by 144
Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics
Wright, S. H. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.021 · Cited by 127
Hirouchi, M., Suzuki, H., Itoda, M., Ozawa, S., Sawada, J.-I., Ieiri, I., Ohtsubo, K., & Sugiyama, Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026422.06207.33 · Cited by 110
Self-citationRobbins, B. L., Greenhaw, J., Connelly, M., & Fridland, A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2304 · Cited by 106
Renal tubular transporters and antiviral drugs: an update
Izzedine, H., Launay‐Vacher, V., & Deray, G. (2005) · AIDS · doi:10.1097/01.aids.0000162333.35686.4c · Cited by 55
Roy, C. J., Baker, R., Washburn, K., & Bray, M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2933-2937.2003 · Cited by 26
Cited by
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
Klaassen, C. D., & Aleksunes, L. M. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002014 · Cited by 807
RUSSEL, F., KOENDERINK, J., & MASEREEUW, R. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.006 · Cited by 383
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
Cihlar, T., & Ray, A. S. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.014 · Cited by 375
Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence
Hall, A. M., Hendry, B. M., Nitsch, D., & Connolly, J. O. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.01.022 · Cited by 373
Side effects of long-term oral antiviral therapy for hepatitis B
Fontana, R. J. (2009) · Hepatology · doi:10.1002/hep.22885 · Cited by 272
Metadata
- Authors
- Imaoka, T., Kusuhara, H., Adachi, M., Schuetz, J. D., Takeuchi, K., & Sugiyama, Y.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 71
- Issue
- 2
- Pages
- 619-627
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2156094398
- Cited by
- 277
- References
- 35
- FWCI
- 8.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.